Canaccord Genuity Maintains a 'Buy' on Atmel (ATML); Pre-announcement In-line with Sector When Allowing for Delayed Payment
Get Alerts ATML Hot Sheet
Price: $8.14 --0%
Rating Summary:
9 Buy, 9 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Rating Summary:
9 Buy, 9 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Join SI Premium – FREE
Canaccord Genuity maintains a 'Buy' on Atmel (NASDAQ: ATML) price target of $11.00
Analyst, Bobby Burleson, said, "Atmel pre-announced lower than guided revenue for its Q4. The revenue shortfall was substantially exacerbated by an $11 million delayed payment from one of the company's Asian distributors. We continue to believe we are near a trough for orders and revenue for the company, and would be buyers on weakness and ahead of looming Win8 touch and a potential Kindle Fire win (large form-factor)."
For an analyst ratings summary and ratings history on Atmel click here. For more ratings news on Atmel click here.
Shares of Atmel closed at $10.10 yesterday.
Analyst, Bobby Burleson, said, "Atmel pre-announced lower than guided revenue for its Q4. The revenue shortfall was substantially exacerbated by an $11 million delayed payment from one of the company's Asian distributors. We continue to believe we are near a trough for orders and revenue for the company, and would be buyers on weakness and ahead of looming Win8 touch and a potential Kindle Fire win (large form-factor)."
For an analyst ratings summary and ratings history on Atmel click here. For more ratings news on Atmel click here.
Shares of Atmel closed at $10.10 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kepler Cheuvreux Upgrades Entain PLC (ENT:LN) (GMVHF) to Buy
- Aon Corp (AON) PT Lowered to $360 at BMO Capital
- Chardan Assumes Rocket Pharmaceuticals (RCKT) at Buy
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
KindleSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share